John Bertrand (CEO, Digital Diagnostics) speaks with Physician's Weekly about LumineticsCore™, an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy, including macular edema, to detect disease before it leads to blindness. Also, regular contributor Dr. MedLaw discusses the role of private equity in your practice.
AI Diagnostics, Private Equity in Your Practice